PLoS ONE (Jan 2023)

A nonstructural protein 1 capture enzyme-linked immunosorbent assay specific for dengue viruses.

  • Pei-Yin Lim,
  • Appanna Ramapraba,
  • Thomas Loy,
  • Angeline Rouers,
  • Tun-Linn Thein,
  • Yee-Sin Leo,
  • Dennis R Burton,
  • Katja Fink,
  • Cheng-I Wang

DOI
https://doi.org/10.1371/journal.pone.0285878
Journal volume & issue
Vol. 18, no. 5
p. e0285878

Abstract

Read online

Dengue non-structural protein (NS1) is an important diagnostic marker during the acute phase of infection. Because NS1 is partially conserved across the flaviviruses, a highly specific DENV NS-1 diagnostic test is needed to differentiate dengue infection from Zika virus (ZIKV) infection. In this study, we characterized three newly isolated antibodies against NS1 (A2, D6 and D8) from a dengue-infected patient and a previously published human anti-NS1 antibody (Den3). All four antibodies recognized multimeric forms of NS1 from different serotypes. A2 bound to NS1 from DENV-1, -2, and -3, D6 bound to NS1 from DENV-1, -2, and -4, and D8 and Den3 interacted with NS1 from all four dengue serotypes. Using a competition ELISA, we found that A2 and D6 bound to overlapping epitopes on NS1 whereas D8 recognized an epitope distinct from A2 and D6. In addition, we developed a capture ELISA that specifically detected NS1 from dengue viruses, but not ZIKV, using Den3 as the capture antibody and D8 as the detecting antibody. This assay detected NS1 from all the tested dengue virus strains and dengue-infected patients. In conclusion, we established a dengue-specific capture ELISA using human antibodies against NS1. This assay has the potential to be developed as a point-of-care diagnostic tool.